ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,184.49
0.52%
Dow Jones
38,778.10
0.00%
Gold vs US Dollar
2,319.035
-0.06%
Brent Oil
83.815
-0.10%
Bitcoin
64,893.21
-2.40%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) News

West Pharmaceutical Serv... (WST)

West Pharmaceutical Services Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:WST
DateTimeSourceHeadlineSymbolCompany
13/06/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
29/05/202411:00PR Newswire (US)West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene TherapyNYSE:WSTWest Pharmaceutical Services Inc
28/05/202411:00PR Newswire (US)West to Participate in Upcoming Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
22/05/202421:05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:WSTWest Pharmaceutical Services Inc
10/05/202418:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
09/05/202420:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
07/05/202420:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
30/04/202411:00PR Newswire (US)West to Participate in Upcoming Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
25/04/202411:00PR Newswire (US)West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
11/04/202411:00PR Newswire (US)West to Host First-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
01/03/202421:24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:WSTWest Pharmaceutical Services Inc
01/03/202418:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
29/02/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
28/02/202421:30PR Newswire (US)West to Participate in Upcoming Investor ConferencesNYSE:WSTWest Pharmaceutical Services Inc
27/02/202421:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
27/02/202416:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
22/02/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
20/02/202421:44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:WSTWest Pharmaceutical Services Inc
20/02/202411:00PR Newswire (US)West Announces Second-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
15/02/202412:51Edgar (US Regulatory)Form 8-K - Current reportNYSE:WSTWest Pharmaceutical Services Inc
15/02/202411:00PR Newswire (US)West Announces Fourth-Quarter and Full-Year 2023 ResultsNYSE:WSTWest Pharmaceutical Services Inc
07/02/202413:00PR Newswire (US)West Named to Newsweek's America's Greatest Workplaces 2024 for DiversityNYSE:WSTWest Pharmaceutical Services Inc
 Showing the most relevant articles for your search:NYSE:WST

Your Recent History

LSE
BF84
Cred Ag Co 31
LSE
SAUA
Steel Auth.gdr
BOV
TIMS3R
TIM ON
BIT
I08985
Intesa Sanpaolo
USOTC
ECRTF
Atex Resources (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved